Ethicon, Professional Wound Care

Ethicon, part of Johnson & Johnson, specializes in advanced medical devices that enhance surgical procedures, improving outcomes for healthcare providers and patients alike. Ethicon focuses on developing medical devices aimed at enhancing surgical procedures. Headquartered in Somerville, US, the company operates as a subsidiary of Johnson & Johnson. The CEO, Benjamin Manico, oversees its operations.

Ethicon has been involved in 2 investment deals. Ethicon Surgical Technologies develops advanced medical devices to improve surgical procedures and patient outcomes. Their key products include the ENSEAL™ X1 Tissue Sealers for efficient tissue sealing and the MONARCH™ Robotic Platform that aids minimally invasive surgeries. These innovations cater to healthcare professionals globally, addressing critical surgical challenges.

Ethicon's revenue predominantly comes from direct sales of surgical products to hospitals and surgical centers, alongside partnerships with medical distributors. Transactions typically involve hospitals purchasing devices for surgical procedures under the ENSEAL™ and MONARCH™ brands, ensuring they are equipped for ongoing operations. The pricing varies based on product type, volume, and contractual agreements with healthcare facilities, reflecting a combination of direct sales and strategic partnerships. Ethicon plans to launch new products designed to further enhance surgical techniques; however, specific release dates have not been disclosed.

The company is targeting expansion into emerging markets, focusing on regions in Asia-Pacific and Europe by 2025. Recent funding has been utilized to support these initiatives, especially after One Equity Partners exited its stake in the company.